PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1572018
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1572018
Percutaneous Nephrolithotomy
Global Percutaneous Nephrolithotomy Market to Reach US$445.2 Million by 2030
The global market for Percutaneous Nephrolithotomy estimated at US$328.4 Million in the year 2023, is expected to reach US$445.2 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030.
The U.S. Market is Estimated at US$87.7 Million While China is Forecast to Grow at 6.6% CAGR
The Percutaneous Nephrolithotomy market in the U.S. is estimated at US$87.7 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$93.6 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.
Global Percutaneous Nephrolithotomy Market - Key Trends and Drivers Summarized
What Is Percutaneous Nephrolithotomy and Why Is It the Preferred Treatment for Large Kidney Stones?
Percutaneous Nephrolithotomy (PCNL) is a minimally invasive surgical procedure used to remove large or complex kidney stones that cannot be effectively treated through less invasive techniques such as extracorporeal shock wave lithotripsy (ESWL) or ureteroscopy. But what makes PCNL distinct and why is it the go-to choice for large renal calculi? The procedure involves making a small incision, usually less than one centimeter, in the patient’s back through which a nephroscope—a specialized surgical instrument—is inserted directly into the kidney. This allows the surgeon to visualize the stones and use instruments to break them into smaller pieces for removal. A tube is often placed temporarily to ensure proper drainage and healing post-procedure. PCNL is particularly effective for stones larger than 2 cm in diameter, staghorn stones, or when stones are located in challenging anatomical locations within the kidney. The technique is highly efficient, with a stone clearance rate exceeding 90% in most cases, making it the preferred option for treating large or multiple stones in a single setting. Compared to open surgery, PCNL is associated with less postoperative pain, shorter hospital stays, and quicker recovery times, providing a significant advantage to patients who need a definitive solution to complex kidney stones.
How Have Recent Technological Advances Enhanced the Safety and Efficacy of PCNL?
The field of Percutaneous Nephrolithotomy has benefited immensely from technological advancements that have significantly improved the safety profile, precision, and outcomes of the procedure. One of the most noteworthy developments is the miniaturization of surgical instruments, leading to what is known as mini-PCNL or ultra-mini-PCNL, which uses even smaller nephroscopes and access tracts. This technique reduces the risk of bleeding and minimizes trauma to the kidney, making it suitable for pediatric patients and adults alike. Another pivotal innovation is the use of advanced imaging modalities, such as fluoroscopy, ultrasound, and real-time CT guidance, which allow for more precise stone targeting and safer access to the kidney, even in anatomically complex cases. Furthermore, new lithotripters, including laser and pneumatic devices, provide enhanced power for fragmenting hard stones, thus reducing the need for repeat procedures. These energy sources have improved efficiency, allowing surgeons to break down larger stones more quickly while preserving healthy tissue. The integration of robotics and computer-assisted navigation in PCNL is also on the horizon, promising to further increase accuracy and reduce the learning curve for urologists. Additionally, single-step dilation techniques and balloon dilators have simplified the process of creating the nephrostomy tract, decreasing operative time and lowering the incidence of complications. With these advancements, PCNL has become not only safer but also more adaptable to a wider range of patient profiles, including those with complex renal anatomy, solitary kidneys, or multiple co-morbidities, thereby expanding its utility in modern urological practice.
Why Is PCNL Becoming the Preferred Treatment Option Across Different Patient Demographics?
The adoption of Percutaneous Nephrolithotomy is steadily increasing across various patient demographics, reflecting its versatility and efficacy in addressing complex stone disease. In adult populations, PCNL is becoming the first-line option for managing large or multiple stones, as well as for cases where non-invasive methods have failed. The procedure’s high success rate in clearing stones, combined with its relatively low recurrence rate, makes it an attractive choice for patients seeking a definitive solution to their condition. Pediatric urology is another area where PCNL is gaining traction, thanks to the development of miniaturized instruments and lower-risk techniques. In children, PCNL offers a safe alternative for treating symptomatic stones that would otherwise require multiple procedures. Elderly patients, who often present with multiple comorbid conditions, also benefit from PCNL’s minimally invasive nature, which results in a lower overall complication rate compared to open surgery. Moreover, individuals with unique anatomical challenges, such as horseshoe kidneys or patients with a solitary kidney, are increasingly undergoing PCNL due to the procedure’s adaptability and the surgeon’s ability to tailor the approach using specialized equipment. The application of PCNL is further expanding to include obese patients, where the percutaneous approach offers a clear advantage over more invasive options, reducing surgical stress and recovery time. This broadening acceptance of PCNL across diverse patient groups is not just a testament to the procedure’s versatility but also to the growing expertise of urologists in customizing PCNL techniques to meet the specific needs of different patient populations.
What’s Fueling the Growth of the Percutaneous Nephrolithotomy Market?
The growth in the Percutaneous Nephrolithotomy market is driven by several factors, including technological advancements, the rising incidence of kidney stone disease, and increasing patient and clinician awareness of minimally invasive options. One of the primary growth drivers is the global rise in the prevalence of nephrolithiasis, which is closely linked to lifestyle factors such as dietary habits, obesity, and metabolic disorders. With kidney stone disease becoming more common across age groups, there is a growing demand for effective surgical treatments like PCNL. Additionally, technological innovations in surgical equipment and imaging modalities are enhancing the safety and precision of PCNL, making it a more viable option for a broader range of patients, including those with complex anatomy or high-risk profiles. The availability of miniaturized instruments has expanded the patient base for PCNL, particularly in pediatric and geriatric care, where traditional PCNL might have been deemed too invasive. Another key factor is the increasing preference among patients and healthcare providers for minimally invasive procedures, which are associated with shorter recovery times, fewer complications, and better cosmetic outcomes. The growth of specialized urology centers and the presence of skilled surgeons who are trained in advanced PCNL techniques are also contributing to market expansion. Moreover, regulatory approval of new PCNL devices and supportive healthcare policies aimed at improving access to specialized surgical care are encouraging more widespread adoption. The integration of robotic systems and computer-assisted navigation is poised to further propel the market, as these technologies promise to enhance precision and reduce the procedural learning curve. Collectively, these factors are shaping the trajectory of the PCNL market, positioning it for robust growth as the demand for effective and minimally invasive kidney stone treatments continues to rise.
Select Competitors (Total 42 Featured) -
- Boston Scientific Corporation
- Cook Medical
- Electro Medical Systems SA
- innoMedicus AG
- Karl Storz Se & Co. KG
- Olympus Corporation
- PolyDiagnost
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Percutaneous Nephrolithotomy - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Growing Prevalence of Kidney Stones Globally Spurs Demand for Minimally Invasive Surgical Techniques
- Advancements in Imaging Technologies Strengthen the Business Case for PCNL in Complex Stone Management
- Rising Adoption of Miniaturized Instruments Expands Addressable Market Opportunity in Pediatric and Geriatric Segments
- Integration of Robotics and Computer-Assisted Navigation Propels Market Growth in High-Precision Stone Removal
- Improved Post-Operative Outcomes and Reduced Recovery Times Sustain Growth of PCNL in High-Risk Patient Groups
- Surge in Health Awareness and Early Diagnosis Accelerates Demand for Surgical Stone Management Solutions
- Technological Innovations in Lithotripters and Energy Sources Strengthen PCNL's Position in the Kidney Stone Treatment Spectrum
- Rising Geriatric Population and Associated Urological Disorders Expand the Addressable Market for PCNL
- Increasing Medical Tourism in Emerging Markets Generates New Opportunities for PCNL Procedures
- High Incidence of Lifestyle-Related Risk Factors for Nephrolithiasis Creates Sustained Demand for Surgical Interventions
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- TABLE 4: World Percutaneous Nephrolithotomy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
- UNITED STATES
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 5: USA Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 6: USA Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- CANADA
- TABLE 7: Canada Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 8: Canada Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- JAPAN
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 9: Japan Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 10: Japan Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- CHINA
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 11: China Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 12: China Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- EUROPE
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 13: Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 14: Europe Historic Review for Percutaneous Nephrolithotomy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 15: Europe 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- FRANCE
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 16: France Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 17: France Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- GERMANY
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 18: Germany Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 19: Germany Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- ITALY
- TABLE 20: Italy Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: Italy Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- UNITED KINGDOM
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 22: UK Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 23: UK Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- SPAIN
- TABLE 24: Spain Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 25: Spain Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- RUSSIA
- TABLE 26: Russia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: Russia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- REST OF EUROPE
- TABLE 28: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 29: Rest of Europe Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- ASIA-PACIFIC
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 30: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 31: Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 32: Asia-Pacific 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- AUSTRALIA
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- TABLE 33: Australia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 34: Australia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- INDIA
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- TABLE 35: India Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: India Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- SOUTH KOREA
- TABLE 37: South Korea Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 38: South Korea Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- REST OF ASIA-PACIFIC
- TABLE 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 40: Rest of Asia-Pacific Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- LATIN AMERICA
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- TABLE 41: Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 42: Latin America Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: Latin America 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- ARGENTINA
- TABLE 44: Argentina Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 45: Argentina Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- BRAZIL
- TABLE 46: Brazil Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 47: Brazil Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- MEXICO
- TABLE 48: Mexico Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 49: Mexico Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- REST OF LATIN AMERICA
- TABLE 50: Rest of Latin America Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: Rest of Latin America Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- MIDDLE EAST
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- TABLE 52: Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 53: Middle East Historic Review for Percutaneous Nephrolithotomy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 54: Middle East 16-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- IRAN
- TABLE 55: Iran Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 56: Iran Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- ISRAEL
- TABLE 57: Israel Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 58: Israel Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- SAUDI ARABIA
- TABLE 59: Saudi Arabia Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: Saudi Arabia Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- UNITED ARAB EMIRATES
- TABLE 61: UAE Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 62: UAE Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- REST OF MIDDLE EAST
- TABLE 63: Rest of Middle East Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 64: Rest of Middle East Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- AFRICA
- Percutaneous Nephrolithotomy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- TABLE 65: Africa Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: Africa Historic Review for Percutaneous Nephrolithotomy by Segment - Percutaneous Nephrolithotomy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
IV. COMPETITION
